A detailed history of Nbc Securities, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nbc Securities, Inc. holds 24 shares of NBIX stock, worth $3,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 22 9.09%
Holding current value
$3,476
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$123.98 - $146.67 $247 - $293
2 Added 9.09%
24 $3,000
Q2 2025

Jul 08, 2025

BUY
$87.54 - $128.18 $175 - $256
2 Added 10.0%
22 $2,000
Q1 2025

Apr 09, 2025

BUY
$107.22 - $153.29 $2,144 - $3,065
20 New
20 $2,000
Q3 2023

Nov 03, 2023

BUY
$94.02 - $117.1 $1,880 - $2,342
20 New
20 $2,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.